Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2008
03/13/2008US20080064698 1-Phenyl and 1-Pyridylpyrazole Derivatives and Their Use as Pesticides
03/13/2008US20080064697 Antidiabetic agents; somatostatin receptor subtype 5 modulators; noninsulin dependent diabetes mellitus; side effect reduction; synthesis
03/13/2008US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate
03/13/2008US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency
03/13/2008US20080064688 Anti-inflammatory medicaments
03/13/2008US20080064686 Programmed cell death, autoimmunity, inflammation, hyperproliferation; easy formulation, shelf life
03/13/2008US20080064682 1,5-diaryl-3-N-heterocycylcarbonylpyrazoles; antiagglomerants that do not inhibit cyclooxygenases; antiischemic agents
03/13/2008US20080060775 8-Oxyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione; antiyellowing agents for lignin
03/13/2008CA2666686A1 Inhibitors of 5-lipoxygenase activating protein (flap)
03/13/2008CA2665819A1 Small molecule inhibitors of toll-like receptor 9
03/13/2008CA2663100A1 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
03/13/2008CA2662728A1 Substituted bipyridine derivatives and their use
03/13/2008CA2662281A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators
03/13/2008CA2662259A1 Fungicides
03/13/2008CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators
03/12/2008EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
03/12/2008EP1897877A2 Process for producing crystal
03/12/2008EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
03/12/2008EP1897875A1 Process for producing 1-pyridin-4-YL-indoles
03/12/2008EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient
03/12/2008EP1896475A2 Process for the preparation of bicyclic compounds
03/12/2008EP1896473A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
03/12/2008EP1896466A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/12/2008EP1896464A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
03/12/2008EP1896461A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
03/12/2008EP1896454A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR -SECRETASE MODULATION
03/12/2008EP1896453A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
03/12/2008EP1896452A2 N-formyl hydroxylamine compounds
03/12/2008EP1896451A2 Bicyclic derivatives for the treatment of abnormal cell growth
03/12/2008EP1896450A1 2-substituted benzimidazoles
03/12/2008EP1896449A1 Heterocyclylaminoalkyl substituted benzimidazoles
03/12/2008EP1896448A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
03/12/2008EP1896447A2 Methods and intermediates for the preparation of optionally radio-labeled imatinib
03/12/2008EP1896422A2 Tyrosine kinase inhibitors
03/12/2008EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
03/12/2008EP1896412A2 Oxindole derivatives
03/12/2008EP1896029A1 Aminopyrimidines as kinase modulators
03/12/2008EP1896023A2 Chemokine receptor binding compounds
03/12/2008EP1697345B1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
03/12/2008EP1656355B1 Piperazine derivatives and methods of use
03/12/2008EP1581229B1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
03/12/2008EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/12/2008CN101142326A Methods of using dyes in association with nucleic acid staining or detection and associated technology
03/12/2008CN101142285A Reactive azo dyes, methods for the production thereof and their use
03/12/2008CN101142223A Platinum complex compound and organic electroluminescent device
03/12/2008CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
03/12/2008CN101142209A Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
03/12/2008CN101142208A 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
03/12/2008CN101142207A Conversion of 2-pyrazolines to pyrazoles using bromine
03/12/2008CN101142206A Compounds, process for their preparation and use thereof
03/12/2008CN101142199A [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and N A D P H quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in
03/12/2008CN101142194A Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
03/12/2008CN101142189A 2-pyridine derivatives as inhibitors of neutrophile elastase
03/12/2008CN101142188A 2-pyridine derivatives as inhibitors of neutrophile elastase
03/12/2008CN101142185A Indoles useful in the treatment of inflammation
03/12/2008CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease
03/12/2008CN101142180A Pyrrolidine derivatives as histamine h3 receptor antagonists
03/12/2008CN101141959A 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
03/12/2008CN101141958A Benzimidazole derivatives and their use for modulating the GABAA receptor complex
03/12/2008CN101141956A Use of CRTH2 antagonist compounds in therapy
03/12/2008CN101141879A Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
03/12/2008CN101139346A Benzimidazole-derivatives as factor Xa inhibitors
03/12/2008CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists
03/12/2008CN101139342A Substituted trinitrogen azole compound and method for synthesizing same
03/12/2008CN101139341A Indazolamides with analgesic activity
03/12/2008CN101139340A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
03/12/2008CN101139339A Process for producing 1-pyridin-4-yl-indoles
03/12/2008CN100374436C Method for the synthesis of a benzimidazole compound
03/12/2008CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity
03/12/2008CN100374434C Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives
03/12/2008CN100374427C Cyclic compound, process for producing the same, and pest control agent
03/12/2008CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers
03/12/2008CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
03/12/2008CN100374115C Substituted diketopiperazines as oxytocin antagonists
03/11/2008US7342118 Imidazole compounds for the treatment of neurodegenerative disorders
03/11/2008US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
03/11/2008US7342037 Anti-inflammatory medicaments
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342029 Substituted indoles
03/11/2008US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
03/11/2008US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
03/11/2008US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis
03/11/2008US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists
03/11/2008US7342016 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; use in combination with antineoplastic agents such as cisplatin
03/11/2008US7342015 Indole derivatives
03/11/2008US7342014 Diamine derivatives
03/11/2008US7342013 Benzamides and related inhibitors of factor Xa
03/11/2008US7342008 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein
03/11/2008US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
03/11/2008US7341607 Yellow anionic disazo dyes
03/11/2008CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation
03/11/2008CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
03/11/2008CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity
03/11/2008CA2293382C Piperazine derivatives and their use as anti-inflammatory agents
03/11/2008CA2192764C Integrin receptor antagonists
03/06/2008WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
03/06/2008WO2008027542A2 5-substituted isoindoline compounds
03/06/2008WO2008027523A2 Salts of benzimidazolyl pyridyl ethers and formulations thereof